APA (7th ed.) Citation

Ritter, E., Husain, R. A., Hinderhofer, K., Prell, T., Fricke, H., Scholl, S., . . . La Rosée, P. (2011). Ornithine transcarbamylase (OTC) deficiency based on a hemizygous p.R277W mutation causing life-threatening hyperammonemic crisis during treatment for Hodgkin’s lymphoma. Annals of hematology, 90(7), . https://doi.org/10.1007/s00277-010-1106-y

Chicago Style (17th ed.) Citation

Ritter, Ellen, Ralf A. Husain, Katrin Hinderhofer, Tino Prell, Hans-Jörg Fricke, Sebastian Scholl, Andreas Hochhaus, and Paul La Rosée. "Ornithine Transcarbamylase (OTC) Deficiency Based on a Hemizygous P.R277W Mutation Causing Life-threatening Hyperammonemic Crisis During Treatment for Hodgkin’s Lymphoma." Annals of Hematology 90, no. 7 (2011). https://doi.org/10.1007/s00277-010-1106-y.

MLA (9th ed.) Citation

Ritter, Ellen, et al. "Ornithine Transcarbamylase (OTC) Deficiency Based on a Hemizygous P.R277W Mutation Causing Life-threatening Hyperammonemic Crisis During Treatment for Hodgkin’s Lymphoma." Annals of Hematology, vol. 90, no. 7, 2011, https://doi.org/10.1007/s00277-010-1106-y.